Business Context and Reporting Period
Company: Champions Oncology, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 18, 2024
Reporting Period: Fiscal year ended April 30, 2024
This filing serves as a notification that the Company issued a press release on July 18, 2024, regarding its audited financial results for the fiscal year ended April 30, 2024. The press release is attached as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. The filing references an attached press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, the filing text does not provide a clear value for any specific financial metric.
Material Changes
No material changes or comparative financial data are disclosed within the text of this specific filing. The document solely announces the availability of the fiscal year results.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. It explicitly states that the information under Item 2.02 is not deemed "filed" for purposes of Section 18 of the Exchange Act unless expressly incorporated by reference.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Press Release dated July 18, 2024) for actual revenue, net income, and cash flow figures.
- Verify the audited financial statements referenced in the press release for the fiscal year ended April 30, 2024.
- Check for any subsequent filings that may incorporate the press release by reference for legal liability purposes.